158 related articles for article (PubMed ID: 1318205)
1. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
Small DL; Bolzon BJ; Cheung DW
Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
[TBL] [Abstract][Full Text] [Related]
2. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
Prieto D; Simonsen U; Nyborg NC
Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
[TBL] [Abstract][Full Text] [Related]
3. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
4. Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
García-Villalón AL; Padilla J; Fernández N; Monge L; Martínez MA; Gómez B; Diéguez G
Pflugers Arch; 2000 Aug; 440(4):548-55. PubMed ID: 10958338
[TBL] [Abstract][Full Text] [Related]
5. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
Andriantsitohaina R; Stoclet JC
Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
Fabi F; Argiolas L; Ruvolo G; del Basso P
Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
[TBL] [Abstract][Full Text] [Related]
7. Modulation by the endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery.
Thorin E; Atkinson J
Br J Pharmacol; 1994 Jan; 111(1):351-7. PubMed ID: 8012718
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit.
Gustafsson H; Nilsson H
Acta Physiol Scand; 1990 Apr; 138(4):503-7. PubMed ID: 2353579
[TBL] [Abstract][Full Text] [Related]
9. Selective potentiation of extracellular Ca2+-dependent contraction by neuropeptide Y in rabbit mesenteric arteries.
Oshita M; Kigoshi S; Muramatsu I
Gen Pharmacol; 1989; 20(3):363-7. PubMed ID: 2545512
[TBL] [Abstract][Full Text] [Related]
10. Role of endothelium on the effects of neuropeptide Y in mesenteric resistance arteries of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
Andriantsitohaina R; Stoclet JC; Bukoski RD
J Pharmacol Exp Ther; 1991 Apr; 257(1):276-81. PubMed ID: 2019991
[TBL] [Abstract][Full Text] [Related]
11. Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
Bradley E; Law A; Bell D; Johnson CD
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2007-14. PubMed ID: 12742824
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism.
Fallgren B; Arlock P; Edvinsson L
J Auton Nerv Syst; 1993; 44(2-3):151-9. PubMed ID: 8227954
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y potentiates specifically the purinergic component of the neural responses in the guinea pig saphenous artery.
Cheung DW
Circ Res; 1991 May; 68(5):1401-7. PubMed ID: 2018998
[TBL] [Abstract][Full Text] [Related]
14. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
Pernow J; Svenberg T; Lundberg JM
Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
[TBL] [Abstract][Full Text] [Related]
15. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
[TBL] [Abstract][Full Text] [Related]
16. Effect of melatonin in the rat tail artery: role of K+ channels and endothelial factors.
Geary GG; Duckles SP; Krause DN
Br J Pharmacol; 1998 Apr; 123(8):1533-40. PubMed ID: 9605558
[TBL] [Abstract][Full Text] [Related]
17. Endothelium removal does not affect potentiation by neuropeptide Y in rabbit ear artery.
Budai D; Vu HQ; Duckles SP
Eur J Pharmacol; 1989 Sep; 168(1):97-100. PubMed ID: 2583236
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
Adamsson M; Fallgren B; Edvinsson L
Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the selectivity of alpha, beta-methylene ATP in inhibiting vascular responses of the rat in vivo and in vitro.
Dalziel HH; Gray GA; Drummond RM; Furman BL; Sneddon P
Br J Pharmacol; 1990 Apr; 99(4):820-4. PubMed ID: 1972897
[TBL] [Abstract][Full Text] [Related]
20. Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.
Prieto D; Benedito S; Simonsen U; Nyborg NC
Br J Pharmacol; 1991 Mar; 102(3):754-8. PubMed ID: 1364848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
